FDA committee rejects two IQOS MRTP claims, approves one
25th January 2018 - News analysis |
Agency?s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won?t accept broader claims of long-term risk reduction
Agency?s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won?t accept broader claims of long-term risk reduction
U.S. tobacco maker Reynolds American is preparing to test-market a heat-not-burn product which it hopes the regulator will approve as reduced-risk.
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields